adenine has been researched along with Aspergillosis in 19 studies
Aspergillosis: Infections with fungi of the genus ASPERGILLUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We report a case of pulmonary aspergilloma in a severely immunocompromised patient with AIDS who stopped taking systemic antifungal treatment in April 1998 and remained well with little progression of invasive aspergillosis up until March 2002 when he died of acute pancreatitis related to a drug interaction of didanosine and tenofovir." | 3.75 | Long-term suppressive therapy for pulmonary aspergilloma in an immunocompromised man with AIDS. Is it always necessary? ( Yoganathan, K, 2009) |
| "Ibrutinib use in chronic lymphocytic leukemia (CLL) has previously been associated with CNS-A." | 1.56 | Isolated central nervous system Aspergillosis infection in a chronic lymphocytic leukemia patient on Ibrutinib: A case report. ( Barnes, M; Buttar, B; Gondal, K; Kaell, A; Kumar, V; Le, TH; Siddique, H, 2020) |
| "Increased aspergillosis was observed with ibrutinib monotherapy and DA-TEDDi-R." | 1.46 | Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma. ( Bhaumik, S; Butman, JA; Ceribelli, M; Chen, L; Cole, DE; Desai, JV; Dunleavy, K; Gea-Banacloche, J; Heiss, J; Higham, CS; Jaffe, ES; Lionakis, MS; Little, RF; Lucas, N; Melani, C; Pittaluga, S; Roschewski, M; Schmitz, R; Staudt, LM; Steinberg, SM; Stetler-Stevenson, M; Thomas, CJ; Widemann, BC; Wilson, WH; Yang, Y, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (5.26) | 29.6817 |
| 2010's | 9 (47.37) | 24.3611 |
| 2020's | 9 (47.37) | 2.80 |
| Authors | Studies |
|---|---|
| Gavriil, ES | 1 |
| Dimitrakis, S | 1 |
| Papadaki, G | 1 |
| Balaska, S | 1 |
| Lambrinidis, G | 1 |
| Lougiakis, N | 1 |
| Marakos, P | 1 |
| Diallinas, G | 1 |
| Pouli, N | 1 |
| Mikros, E | 1 |
| Asawa, P | 1 |
| Chahine, Z | 1 |
| Vusqa, U | 1 |
| Samhouri, Y | 1 |
| Fazal, S | 1 |
| Booth, E | 1 |
| Backx, M | 1 |
| Joshi, A | 1 |
| Nizami, H | 1 |
| Elmusharaf, N | 1 |
| Petitdemange, A | 1 |
| Martin, A | 1 |
| Ruch, Y | 1 |
| Chatron, E | 1 |
| Karol, A | 1 |
| Hansmann, Y | 1 |
| Nyga, R | 2 |
| Delette, C | 2 |
| Mabille, C | 1 |
| Bennis, Y | 2 |
| Chouaki, T | 2 |
| Boone, M | 1 |
| Maizel, J | 2 |
| Marolleau, JP | 2 |
| Joseph, C | 2 |
| Le, TH | 1 |
| Kumar, V | 1 |
| Gondal, K | 1 |
| Barnes, M | 1 |
| Siddique, H | 1 |
| Buttar, B | 1 |
| Kaell, A | 1 |
| Anastasopoulou, A | 1 |
| DiPippo, AJ | 1 |
| Kontoyiannis, DP | 1 |
| Fiorcari, S | 1 |
| Maffei, R | 1 |
| Vallerini, D | 1 |
| Scarfò, L | 1 |
| Barozzi, P | 1 |
| Maccaferri, M | 1 |
| Potenza, L | 1 |
| Ghia, P | 1 |
| Luppi, M | 1 |
| Marasca, R | 1 |
| Creuzet, E | 1 |
| Nourrisson, C | 1 |
| Chaleteix, C | 1 |
| Poirier, P | 1 |
| Moniot, M | 1 |
| Lionakis, MS | 1 |
| Dunleavy, K | 1 |
| Roschewski, M | 1 |
| Widemann, BC | 1 |
| Butman, JA | 1 |
| Schmitz, R | 1 |
| Yang, Y | 1 |
| Cole, DE | 1 |
| Melani, C | 1 |
| Higham, CS | 1 |
| Desai, JV | 1 |
| Ceribelli, M | 1 |
| Chen, L | 1 |
| Thomas, CJ | 1 |
| Little, RF | 1 |
| Gea-Banacloche, J | 1 |
| Bhaumik, S | 1 |
| Stetler-Stevenson, M | 1 |
| Pittaluga, S | 1 |
| Jaffe, ES | 1 |
| Heiss, J | 1 |
| Lucas, N | 1 |
| Steinberg, SM | 1 |
| Staudt, LM | 1 |
| Wilson, WH | 1 |
| Baron, M | 2 |
| Zini, JM | 1 |
| Challan Belval, T | 1 |
| Vignon, M | 1 |
| Denis, B | 1 |
| Alanio, A | 1 |
| Malphettes, M | 2 |
| Bazaz, R | 1 |
| Denning, DW | 1 |
| Ghez, D | 2 |
| Calleja, A | 1 |
| Protin, C | 1 |
| Ledoux, MP | 1 |
| Damaj, G | 1 |
| Dupont, M | 1 |
| Dreyfus, B | 1 |
| Ferrant, E | 1 |
| Herbaux, C | 1 |
| Laribi, K | 1 |
| Le Calloch, R | 1 |
| Paul, F | 1 |
| Souchet, L | 1 |
| Truchan-Graczyk, M | 1 |
| Delavigne, K | 1 |
| Dartigeas, C | 1 |
| Ysebaert, L | 1 |
| Bercusson, A | 1 |
| Colley, T | 1 |
| Shah, A | 1 |
| Warris, A | 1 |
| Armstrong-James, D | 1 |
| McCarter, SJ | 1 |
| Vijayvargiya, P | 1 |
| Sidana, S | 1 |
| Nault, AM | 1 |
| Lane, CE | 1 |
| Lehman, JS | 1 |
| Wilson, JW | 1 |
| Parikh, SA | 1 |
| Nowakowski, GS | 1 |
| Al-Kali, A | 1 |
| Pouvaret, A | 1 |
| Guery, R | 1 |
| Montillet, M | 1 |
| Molina, TJ | 1 |
| Duréault, A | 1 |
| Bougnoux, ME | 1 |
| Galliot, R | 1 |
| Lanternier, F | 1 |
| Delarue, R | 1 |
| Lortholary, O | 1 |
| Simon, L | 1 |
| Slama, M | 1 |
| Zogheib, E | 1 |
| Blez, D | 1 |
| Blaize, M | 1 |
| Soussain, C | 1 |
| Boissonnas, A | 1 |
| Meghraoui-Kheddar, A | 1 |
| Menezes, N | 1 |
| Portalier, A | 1 |
| Combadière, C | 1 |
| Leblond, V | 1 |
| Fekkar, A | 1 |
| Yoganathan, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Clinical Efficacy and Safety of IBER Salvage Treatment Followed by Ibrutinib Maintenance for Transplant-ineligible Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma (PCNSL): a Multicenter, Single-arm, Prospective Phase II Study[NCT04066920] | Phase 2 | 30 participants (Anticipated) | Interventional | 2019-10-01 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for adenine and Aspergillosis
| Article | Year |
|---|---|
Non-Aspergillus invasive mould infections in patients treated with ibrutinib.
Topics: Adenine; Aged; Anticarcinogenic Agents; Antifungal Agents; Aspergillosis; Aspergillus; Female; Fungi | 2020 |
1 trial available for adenine and Aspergillosis
| Article | Year |
|---|---|
Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib.
Topics: Adenine; Aspergillosis; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Piperidines; P | 2018 |
17 other studies available for adenine and Aspergillosis
| Article | Year |
|---|---|
Structure-activity relationships in fungal nucleobases transporters as dissected by the inhibitory effects of novel purine analogues.
Topics: Antifungal Agents; Aspergillosis; Aspergillus nidulans; Biological Transport; Drug Design; Fungal Pr | 2018 |
Invasive Aspergillosis of the Spleen in the setting of Ibrutinib use.
Topics: Adenine; Aspergillosis; Humans; Invasive Fungal Infections; Piperidines; Spleen | 2022 |
Disseminated invasive aspergillosis in a patient treated with ibrutinib for chronic lymphocytic leukaemia.
Topics: Adenine; Aspergillosis; Humans; Invasive Fungal Infections; Leukemia, Lymphocytic, Chronic, B-Cell; | 2023 |
[Aspergillus spondylodiscitis in a patient treated with ibrutinib].
Topics: Adenine; Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Asp | 2020 |
Ibrutinib related cerebral aspergillosis successfully treated with isavuconazole: a case report.
Topics: Adenine; Antifungal Agents; Aspergillosis; Humans; Nitriles; Piperidines; Pyridines; Triazoles | 2020 |
Isolated central nervous system Aspergillosis infection in a chronic lymphocytic leukemia patient on Ibrutinib: A case report.
Topics: Adenine; Aged; Aspergillosis; Aspergillus; Central Nervous System Infections; Humans; Leukemia, Lymp | 2020 |
BTK Inhibition Impairs the Innate Response Against Fungal Infection in Patients With Chronic Lymphocytic Leukemia.
Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Antineoplastic Agents; Aspergillosis; Aspergillus fumi | 2020 |
Cerebral aspergillosis in a patient on ibrutinib therapy.
Topics: Adenine; Adrenal Cortex Hormones; Aged; Aspergillosis; Aspergillus fumigatus; Brain Diseases; Humans | 2021 |
Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma.
Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Aged; Aged, 80 and over; Animals; Aspergillosis; Brain | 2017 |
Fungal infections in patients treated with ibrutinib: two unusual cases of invasive aspergillosis and cryptococcal meningoencephalitis.
Topics: Adenine; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; | 2017 |
Subacute Invasive Aspergillosis Associated With Sorafenib Therapy for Hepatocellular Carcinoma.
Topics: Adenine; Aspergillosis; Carcinoma, Hepatocellular; Humans; Invasive Fungal Infections; Liver Neoplas | 2018 |
Ibrutinib blocks Btk-dependent NF-ĸB and NFAT responses in human macrophages during
Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Aspergillosis; Aspergillus fumigatus; Cells, Cultured; | 2018 |
A case of ibrutinib-associated aspergillosis presenting with central nervous system, myocardial, pulmonary, intramuscular, and subcutaneous abscesses.
Topics: Abscess; Adenine; Antifungal Agents; Aspergillosis; Humans; Leukemia, B-Cell; Lymphoma, B-Cell; Orga | 2019 |
Concurrent cerebral aspergillosis and abdominal mucormycosis during ibrutinib therapy for chronic lymphocytic leukaemia.
Topics: Adenine; Adult; Aspergillosis; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Mucormycosis; Neoplas | 2019 |
The pharmacokinetic challenge of voriconazole therapy for cerebral aspergillosis in patients treated with ibrutinib.
Topics: Adenine; Aged; Antifungal Agents; Aspergillosis; Cerebrum; Humans; Male; Piperidines; Pyrazoles; Pyr | 2019 |
Ibrutinib induces multiple functional defects in the neutrophil response against
Topics: Adenine; Aspergillosis; Aspergillus fumigatus; Humans; Neutrophils; Piperidines; Spores, Fungal | 2020 |
Long-term suppressive therapy for pulmonary aspergilloma in an immunocompromised man with AIDS. Is it always necessary?
Topics: Adenine; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antifungal Agents; Aspergillosis; D | 2009 |